VASO Corp Files 8-K: Corporate Updates

TL;DR

VASO Corp filed an 8-K on Aug 26, mostly corporate housekeeping & financials.

AI Summary

VASO Corporation filed an 8-K on August 28, 2024, reporting other events and financial statements as of August 26, 2024. The filing details the company's corporate structure and historical name changes, including its former names Vasomedical, Inc. and Future Medical Products Inc. The report is primarily administrative, confirming its status as a public document.

Why It Matters

This filing serves as an official record of corporate events and financial statement disclosures for VASO Corp, providing transparency to investors about the company's structure and reporting.

Risk Assessment

Risk Level: low — The filing appears to be routine administrative and financial reporting, with no immediate indication of significant operational or financial risk.

Key Players & Entities

• VASO Corporation (company) — Registrant
• Vasomedical, Inc. (company) — Former Company Name
• Future Medical Products Inc (company) — Former Company Name
• August 26, 2024 (date) — Date of earliest event reported
• August 28, 2024 (date) — Filing Date

FAQ

Filing Documents

• ea0212610-8k425_vaso.htm (8-K) — 33KB
• 0001213900-24-073043.txt ( ) — 205KB
• vaso-20240826.xsd (EX-101.SCH) — 3KB
• vaso-20240826_lab.xml (EX-101.LAB) — 33KB
• vaso-20240826_pre.xml (EX-101.PRE) — 22KB
• ea0212610-8k425_vaso_htm.xml (XML) — 4KB

01. Other

Item 8.01. Other Events. On August 26, 2024, Vaso Corporation ("Vaso") announced that the extraordinary general meeting of Vaso's stockholders (the "Special Meeting"), which had been scheduled for 10:00 a.m. Eastern Time on August 26, 2024, was adjourned, and will recommence at 10:00 a.m. Eastern Time on September 10, 2024, at the Lever House, 390 Park Avenue, Third Floor, New York, NY 10022. The Special Meeting is being held for the purpose of considering and voting on, among other related business, certain proposals, including with respect to approval of the transactions (the "Business Combination") contemplated by that certain Business Combination Agreement, dated as of December 6, 2023 (the "Business Combination Agreement"), by and among Vaso, Achari Ventures Holdings Corp. I, a Delaware corporation ("Achari"), and Achari Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Achari ("Merger Sub"), among other items. The proposals and related matters are described in more detail in the definitive proxy statement related to the Special Meeting originally filed by Vaso with the United States Securities and Exchange Commission (the "SEC") on August 7, 2024 as amended to date (the "Definitive Proxy Statement"). The record date for the Special Meeting remains the close of business on July 15, 2024. Participants in the Solicitation Vaso and certain of its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from the Company's stockholders in respect of the proposals to be considered and voted on at the Special Meeting as disclosed in the Definitive Proxy Statement. Information concerning the interests of the directors and executive officers of the Company is set forth in the Definitive Proxy Statement available at the SEC's website (www.sec.gov). No Offer or Solicitation This Current Report on Form 8-K is not a proxy

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K ("Current Report") may include, and oral statements made from time to time by representatives of the Company may include, "forward-looking Exchange Act of 1934, as amended. Statements regarding the approval of certain proposals at the Special meeting or the implementation of the Extension Proposals, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Current Report are forward-looking statements. When used in this Current Report, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company. The Company undertakes no obligation to update these statements for revisions or changes after the date of this Current Report, except as required by law.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 27, 2024 VASO CORPORATION By: /s/ Jun Ma Name: Jun Ma Title: Chief Executive Officer and President 3

View Full Filing

View this 8-K filing on SEC EDGAR